جست‌وجوی استاد و پژوهشگر

• Neuroscience
• Molecular Biology
• Genetics
• +۴ مورد دیگر

Panagiotis Politis serves as a Visiting Professor at the European University Cyprus (EUC) School of Medicine and Frankfurt, while maintaining his primary role as Principal Investigator at the Biomedical Research Foundation of the Academy of Athens (BRFAA) since 2015. His academic journey includes a PhD in Biochemistry from Oxford (2000) focusing on chromatin regulation in yeast, preceded by a NASA Planetary Biology Internship at the Salk Institute (1998) and BSc in Biology from Patras (1996). His research qualifications include: PhD in Biochemistry, University of Oxford (2000) BSc in Biology, University of Patras (1996) Dr. Politis's research program centers on neurodegenerative mechanisms , particularly Parkinson's disease pathophysiology, where he investigates long non-coding RNAs, nuclear receptor signaling, and neural stem cell dynamics. His work integrates molecular, cellular, and systems neuroscience approaches to dissect epigenetic regulation in neurodevelopment and neurodegeneration, with significant contributions to understanding transcription factor networks (Prox1, NR5A2) in neuronal fate decisions and disease progression. Current projects explore auto-antibody pathophysiology and RNA splicing mechanisms in brain development. Analysis of his 2004-2019 publications reveals a consistent trajectory from chromatin biology toward neurological disease mechanisms, with increasing focus on human iPSC models, non-coding RNA networks, and translational applications in neurodegeneration and neuro-oncology. Key thematic clusters include transcriptional regulation in neural development (2010-2017), Parkinson's disease modeling (2017-2019), and cancer-related neural mechanisms (2013-2018). His scientific distinctions include: Fulbright Research Scholar Fellowship (2008) NASA Planetary Biology Fellowship (1998) Multiple Oxford-based awards including Florey EPA studentship Young Scientist Travel Award from International Society of Biochemistry Dr. Politis has secured €2M+ in research funding as Principal Investigator for 10+ projects from Greek Secretariat of Research (Excellence/SYNERGASIA schemes), Fondation Sante, and EU COST actions. His grants investigate Parkinson's mechanisms, neural development, and renal fibrosis, with recent focus on anti-GAD65 auto-antibodies (2017-present) and RNA splicing in brain development (2017-present). He actively mentors junior researchers through BRFAA's training programs and has organized major conferences including FENS symposia and Hellenic Neuroscience Society meetings. His research is conducted through the BRFAA Molecular Neurobiology Laboratory, which employs advanced techniques in iPSC modeling, molecular genetics, and neuropathology to investigate neurodegenerative mechanisms and therapeutic targets.

Guillaume Bourqueمشاهده پروفایل

استاد

• Bioinformatics
• Computational Genomics
• Comparative Genomics
• +۵ مورد دیگر

Guillaume Bourque is a Professor in the Department of Human Genetics at McGill University's Faculty of Medicine. He serves as an Investigator at the Victor Phillip Dahdaleh Institute of Genomic Medicine and as the Scientific Director of the Canadian Centre for Computational Genomics (C3G). His laboratory is based at 740 Dr Penfield Ave, Room 6103, Montréal, Québec, Canada, H3A 1A4, where he leads research in computational genomics and bioinformatics. Professor Bourque's research focuses on understanding mammalian genomes using comparative genomic and epigenomic analyses. His lab investigates the evolution of regulatory sequences , the role of transposable elements in gene regulation , and the impact of genome rearrangements in evolution and cancer . His team develops computational methods and resources for the functional annotation of genomes with special emphasis on sequencing-based assays including ChIP-seq, RNA-Seq, exome- and whole-genome sequencing, and single-cell analysis. The lab's work involves examining billions of DNA base pairs to interpret how variation impacts basic biology and disease. Recent publications (2024-2025) demonstrate Bourque's leadership in pangenome graph construction , transposable element analysis , epigenomic profiling , and cancer genomics . His work spans multiple disciplines from basic genome evolution to clinical applications in cancer and infectious disease. Notable projects include the development of tools like DeepPolisher for genome assembly polishing and contributions to understanding the genomic basis of long COVID. Bourque's laboratory is actively recruiting postdocs and graduate students with backgrounds in programming or statistics. The lab emphasizes quantitative approaches to biology, requiring applicants to have experience in quantitative biology as a plus. His collaborative work extends across multiple institutions and international consortia, reflecting the interdisciplinary nature of modern genomic research.

Xi-Long Zhengمشاهده پروفایل

استاد

• Vascular Smooth Muscle Biology
• Atherosclerosis
• Vascular Disease Mechanisms
• +۴ مورد دیگر

Xi-Long Zheng is a tenured Professor in the Department of Biochemistry and Molecular Biology and Department of Physiology and Pharmacology at the Cumming School of Medicine, University of Calgary. He holds additional appointments as a Member of the Libin Cardiovascular Institute and Associate Member of both the Snyder Institute for Chronic Diseases and Arnie Charbonneau Cancer Institute. His research focuses on vascular smooth muscle biology and its role in cardiovascular diseases. Doctor of Medicine, Hunan Medical University (1986) M.S. in Pharmacology, Hunan Medical University (1989) Doctor of Philosophy in Pharmacology, University of Calgary (1997) Dr. Zheng's research centers on vascular smooth muscle cell differentiation, proliferation, and phenotypic switching in vascular diseases. His laboratory investigates mechanisms of vascular smooth muscle dedifferentiation in atherosclerosis, abdominal aortic aneurysms, and vascular stiffness. Current work explores ferroptosis, epigenetic regulation (particularly BRD4), and PCSK9 functions in vascular pathologies. His studies integrate molecular, cellular, and in vivo approaches to identify novel therapeutic targets for cardiovascular diseases. Analysis of his recent publications reveals strong emphasis on cell death mechanisms (ferroptosis, cuproptosis), epigenetic regulation, lipid metabolism, and immune-vascular interactions in atherosclerosis. His work demonstrates increasing focus on translational applications targeting vascular smooth muscle phenotypic switching and plaque stability. Alberta Innovates ‒ Health Solutions Senior Scholar Award (2008-2015) Heart & Stroke Foundation New Investigator Award (2001-2006) CIHR/Hypertension Society Scholarship Award (2001-2004) Heart & Stroke Foundation Fellowship Award (1999-2001) AHFMR Independent Investigator Award (2008) Dr. Zheng serves on grant panels for Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada. He is an editorial board member for Biochemical Journal and other scholarly publications. His laboratory receives funding from CIHR and NSERC for projects including smooth muscle PCSK9 in abdominal aortic aneurysm pathogenesis, smooth muscle autophagy in vascular aging, and epigenetic regulation of smooth muscle plasticity. The Zheng Lab investigates vascular smooth muscle functions across multiple organ systems including blood vessels, gastrointestinal tract, bladder, and uterus. His research has established critical mechanisms in vascular smooth muscle differentiation and cell cycle regulation, contributing over 100 peer-reviewed publications in high-impact journals including PNAS, ATVB, Diabetologia, JBC, and Hypertension.

Zhipeng Luمشاهده پروفایل

دانشیار

• RNA biology
• RNA structures
• RNA machines
• +۷ مورد دیگر

Zhipeng Lu is currently an Associate Professor of Pharmacology and Pharmaceutical Sciences at the University of Southern California (USC) School of Pharmacy. His research focuses on understanding RNA molecules and their structural complexity as a second layer of genetic instructions beyond protein encoding. He directs the Lu Lab at USC, which develops and applies novel technologies to investigate RNA structures, interactions, chemical modifications, and functions in cellular processes and animal development. Dr. Lu's research interests center on "RNA machines" in living cells, with particular emphasis on how RNA molecules fold into structures and form intermolecular interactions to execute genetic instructions. His work spans multiple dimensions of RNA biology, including RNA structure-function relationships, RNA-protein interactions, RNA modifications, and the role of RNA in human diseases such as genetic disorders and viral infections. The lab combines computational, chemical, and biological approaches to elucidate fundamental mechanisms of RNA machines, with the ultimate goal of developing new understanding and therapies targeting human diseases. Analysis of Dr. Lu's publication history reveals a strong trajectory in RNA structure and interaction mapping technologies. His work has evolved from foundational studies on RNA processing and modification to developing innovative high-throughput methods like PARIS and RISE for analyzing RNA interactomes. Recent publications focus on specific RNA systems like XIST and snoRNAs, demonstrating how his lab has moved from method development to applying these tools to solve longstanding biological questions in epigenetics and RNA therapeutics. Dr. Lu has received numerous prestigious awards recognizing his contributions to RNA research: NHGRI K99/R00 NIH Pathway to Independence Award (2017-2022) RNA Society Scaringe Award (2017) Stanford University Jump Start Award for Excellence in Research (2016-2017) Damon Runyon-Sohn Fellowship (2015-2017) His research is supported by multiple funding sources from organizations including the National Institutes of Health and other foundations. The Lu Lab is actively recruiting PhD students and postdoctoral researchers to work on several cutting-edge directions including RNA structures, interaction networks, RNA modification mechanisms, and their roles in development and disease. The lab integrates biological, chemical, and computational approaches to advance RNA biology and push forward RNA medicine. The Lu Lab at USC is a dynamic research environment focused on "RNA machines" with recent highlights including solving aspects of the orphan snoRNA problem and discovering snoRNAs that control eMet tRNA activity. The lab's vision emphasizes creative exploration of RNA biology, with researchers encouraged to pursue innovative ideas much like "wild animals running in the African savannah." Current research directions include analysis of RNA structures, interaction networks, RNA modification mechanisms, and their roles in development and disease, with applications to genetic disorders, cancers, and viral infections.

Adele Murrellمشاهده پروفایل

استاد

• Epigenetics
• Genomic Imprinting
• DNA Methylation
• +۶ مورد دیگر

Professor Adele Murrell is a Professor of Epigenetics in the Department of Life Sciences at the University of Bath's Faculty of Science. She serves as Co-Director of the Centre for Therapeutic Innovation and is affiliated with both the Centre for Mathematical Biology and the Centre for Bioengineering & Biomedical Technologies (CBio). She is currently accepting doctoral students and maintains an active research program with multiple ongoing projects. Her research focuses on understanding how cells establish and maintain their specific identities through epigenetic mechanisms. Her work centers on epigenetic barriers and cell identity, genomic imprinting as a model epigenetic system, long-range epigenetic silencing in cancer, and epigenetic reprogramming during metastasis. She investigates how higher-order chromatin structure and epigenetic modifications shape the genome within the nucleus to constitute cell identity and provide memory of developmental origins. Her current work examines colon cancer and liver metastasis, focusing on changes in DNA methylation and its demethylation intermediates such as 5-hydroxymethylcytosine. Analysis of Professor Murrell's recent publications reveals a strong focus on DNA hydroxymethylation patterns in cancer progression, particularly in colorectal cancer metastasis. Her work bridges molecular epigenetics with clinical applications, exploring how epigenetic changes during metastasis could be targeted to prevent cancer spread. She has developed novel techniques for detecting epigenetic modifications and has made significant contributions to understanding allele-specific chromatin domains and genomic imprinting mechanisms. Professor Murrell leads multiple research projects including 'Two stages of genome wide 5-hydroxymethylcytosine (5hmC) reprogramming during colorectal carcinogenesis and liver metastasis' funded by the MRC until February 2024, and 'Modelling the fits and starts of how genes burst into expression' funded by The Leverhulme Trust until June 2024. She was also a Co-Investigator on the 'Multi User High-Content Confocal Microscope' project funded by the Biotechnology and Biological Sciences Research Council. Her laboratory work connects with UN Sustainable Development Goals, particularly those related to health and well-being. Her fingerprint analysis shows strong activity in Epigenetics (100%), DNA Methylation (94%), Allele research (73%), Methylation studies (69%), Genomic Imprinting (60%), CTCF research (56%), Promoter Region analysis (44%), and Differentially Methylated Regions (34%).

Haiyan Huمشاهده پروفایل

استاد

• Computational Biology
• Bioinformatics
• Machine Learning
• +۱۰ مورد دیگر

Haiyan Hu is a Professor at the Department of Computer Science, University of Central Florida (College of Engineering and Computer Science), where she leads the Data Integration and Knowledge Discovery Lab. Her work bridges computational biology, bioinformatics, and machine learning to address challenges in biomedical research, particularly in understanding gene regulation, microRNA, and long non-coding RNA mechanisms linked to diseases like cancer, Alzheimer’s, and Parkinson’s. Education Ph.D. in Computer Science, University of Southern California Research Focus : Dr. Hu’s research applies big data mining, statistical pattern recognition, and deep learning to genomic and epigenetic data analysis. She develops computational methods for knowledge discovery in complex biological systems, with emphasis on disease mechanisms and regulatory networks. Scientific Recognition : NSF CAREER Award, 2012-2019 UCF Research Incentive Awards (2014, 2019) UCF Reach for the Stars Award (2015) Labs and Collaborations : Dr. Hu directs the Data Integration and Knowledge Discovery Lab, fostering interdisciplinary research that integrates computational approaches with biomedical applications.

Xiaowen Baiمشاهده پروفایل

استاد

• Stem Cell Biology
• Neurodegeneration
• Cardiotoxicity
• +۵ مورد دیگر

Xiaowen Bai, MD, PhD, is a Professor in the Department of Cell Biology, Neurobiology and Anatomy at the Medical College of Wisconsin. His research focuses on leveraging stem cells to model neurodegenerative diseases and cardiac disorders, with a particular emphasis on non-coding RNAs, mitochondria, and environmental stressors like anesthetics and alcohol. He holds a leadership role as Executive Director of Hematology at the World Federation of Chinese Medicine Societies (WFCMS). Education: MD, Shanxi Medical University (1993) PhD, Beijing University Stem Cell Center (2004) Postdoctoral Training, University of Texas MD Anderson Cancer Center (2007) Research Interests: Neurodegeneration mechanisms involving microRNAs, lncRNAs, and mitochondrial dysfunction Stem cell-based therapies for myocardial regeneration Diabetic cardiomyopathy pathogenesis and cardioprotection 3D organoid models for studying anesthetic and alcohol neurotoxicity Recent Work: Recent publications emphasize translational studies using human-induced pluripotent stem cell (iPSC)-derived models to investigate alcohol-induced brain injury, anesthetic neurotoxicity, and cardiac fibrosis. His lab also explores immunomodulatory pathways and redox signaling in inflammatory diseases. Labs/Teams: The Bai Lab develops novel in vitro models for disease modeling and drug testing, focusing on cerebral organoids and cardiac organoids to bridge basic research and clinical applications.

Norman Van Rhijnمشاهده پروفایل

پژوهشگر ارشد

• Antimicrobial Resistance (AMR)
• Climate Change Impact on Fungal Pathogens
• One Health
• +۳ مورد دیگر

Norman Van Rhijn is a Wellcome Trust Early Career Fellow at the University of Manchester's Division of Evolution, Infection and Genomics. His research focuses on microbial evolution with specific emphasis on fungal pathogens, particularly Aspergillus fumigatus . He leads work on antimicrobial resistance (AMR), climate change impacts on fungal diseases, and genetic tools for non-model organisms. He holds affiliations with MERman (Microbial Evolution Research Manchster) and the Manchester Fungal Infection Group (MFIG). Education: BSc Biology (Leiden University), MSc Medical Mycology (University of Manchester), PhD in Molecular Biology (University of Manchester). Research highlights include developing CRISPR-based genome editing methodologies, studying fungal adaptation to environmental pressures, and investigating dual-use fungicides. His work contributes to UN Sustainable Development Goals related to health and environmental sustainability. Award: Wellcome Trust Early Career Fellowship. Labs/Teams: PI in the MFIG project, editorial board member for mBio , and active in professional societies including the Microbiology Society and British Society for Medical Mycology.

• Molecular Virology
• RNA Biology
• Plant Biotechnology
• +۵ مورد دیگر

Prof. Dr. Sven-Erik Behrens serves as a Professor in the Department of Microbial Biotechnology at the Faculty of Natural Sciences I of Martin Luther University Halle-Wittenberg. He is affiliated with the Protein Research Center 'Charles Tanford' and maintains an active research program focused on RNA biology, molecular virology, and biotechnological applications. His primary research interests encompass RNA-based plant protection strategies, viral replication mechanisms (particularly for flaviviruses and plant viruses), and innovative vaccine development using Kluyveromyces lactis yeast expression systems. Behrens' work investigates fundamental RNA-protein interactions, RNA chaperone activities, and the molecular basis of antiviral defense mechanisms in plants. His laboratory explores how RNA accessibility influences viral replication and how this knowledge can be harnessed for developing novel RNA-based antiviral strategies. Analysis of his recent publications (2021-2025) reveals a clear research trajectory focused on identifying accessible RNA sites for targeted antiviral applications, optimizing yeast-based vaccine platforms for both plant and animal pathogens, and investigating the role of non-coding RNAs in plant development and stress responses. His work spans multiple disciplines including plant virology, medical virology, and microbial biotechnology, demonstrating translational research from basic molecular mechanisms to practical applications. Prof. Behrens leads research in the Department of Microbial Biotechnology, collaborating with various groups working on plant-pathogen interactions and vaccine development. His laboratory employs advanced techniques including RNA structure probing, fluorescence-based assays for RNA chaperone activity, and plant in vitro systems for studying viral replication. The research demonstrates significant potential for developing novel approaches to combat viral diseases in both agricultural and medical contexts.

Dimitris Lagosمشاهده پروفایل

استاد

• RNA Biology
• Immunology
• Cancer Research
• +۹ مورد دیگر

Professor Dimitris Lagos is a faculty member at the Hull York Medical School under the University of York . He holds the role of Professor of Immunology and serves as the Director of Research , leading the Departmental Research Committee. His academic career includes prior appointments as Lecturer , Senior Lecturer , and Reader at Hull York Medical School. Professor Lagos' research focuses on RNA Biology and RNA Medicine , specifically investigating RNA-driven immune gene regulation in infection and cancer. His group explores transcriptome instability in cancer, sexual dimorphism in lymphocytes, and circulating non-coding RNAs as disease biomarkers. He utilizes advanced transcriptomics platforms like long-read RNA sequencing and spatial omics for discovery, with pharmacological RNA targeting as a therapeutic strategy. His recent publications highlight trends in immune checkpoint regulation (e.g., PD-L1, IDO1), Cancer Immunology , and RNA-based biomarkers for disease prognosis. He leads the MANIFEST immuno-oncology consortium and collaborates with Oxford Nanopore Technologies . His group has historically spearheaded molecular pathology themes in global infectious disease consortia, including the UK Coronavirus Immunology Consortium . Professor Lagos is funded by Cancer Research UK and UKRI (MRC and BBSRC). He supervises postgraduate students Mags Gwynne , Ali Deghany , Charlotte Booth , and Molly Cartwright . His work bridges gene regulation , RNA Medicine , and Immunology , emphasizing translational applications.

Timothy Bredyمشاهده پروفایل

دانشیار

• Epigenetics
• Fear-Related Memory
• RNA Biology
• +۶ مورد دیگر

Associate Professor Timothy Bredy is a leading figure in cognitive neuroepigenetics at the Queensland Brain Institute (QBI) , focusing on how epigenetic modifications and RNA dynamics regulate fear-related memory and psychiatric disorders like PTSD. His research explores the interplay between environmental experiences and genomic activity, particularly through non-coding RNA and DNA methylation. University: University of Queensland School: Faculty of Health, Medicine and Behavioural Sciences Role: Professorial Research Fellow and Group Leader Research Interests span epigenetic mechanisms in memory formation, RNA modifications in synaptic plasticity, and therapeutic applications for anxiety disorders. He pioneered discoveries linking dynamic DNA structures (e.g., G-quadruplexes) and RNA methylation to memory stability. Recent Work includes studies on RNA-based therapeutics, stress-induced epigenetic inheritance, and synaptic long noncoding RNA activity. His scientific awards encompass NHMRC and ARC grants for neuroepigenetics research. Key Collaborators: Paul Marshall, Esmi Zajaczkowski Labs: Bredy Laboratory at QBI

• Biosensors
• Bio-nanotechnology
• Bioregenerative Life Support
• +۴ مورد دیگر

Dr. D. Marshall Porterfield is a Professor of Agricultural & Biological Engineering at Purdue University, specializing in biosensors, bio-nanotechnology, and space biology. His research focuses on developing technologies for bioregenerative life support systems and nutrient delivery in microgravity environments. He served as NASA's Division Director for Space Life and Physical Sciences (2012-2016), pioneering initiatives like geneLAB and materialsLAB to advance space research utilization. His work bridges engineering and biology, with applications in space exploration and terrestrial challenges. Porterfield holds leadership roles in organizations like the American Society for Gravitational and Space Research and the Institute for Biological Engineering. He has authored over 100 peer-reviewed papers and holds patents in biosensor technology. Awards include the Halstead Investigator Award and election to the AIMBE College of Fellows. His research portfolio includes lab-on-a-chip devices, biomimetic sensors, and gravitational physiology studies, with recent emphasis on lunar agriculture and space radiation mitigation. His articles highlight advancements in space microbiology, extraterrestrial crop systems, and molecular responses to spaceflight. Key themes include optimizing oxygen delivery for hydroponics, detecting cancer biomarkers via microtest tech, and understanding aging in space environments. Porterfield collaborates across disciplines, leveraging Purdue's facilities like the Birck Nanotechnology Center and Discovery Park for interdisciplinary innovation.

Sean McKennaمشاهده پروفایل

استاد

• RNA Biochemistry
• Cancer Biology
• Virology
• +۳ مورد دیگر

Sean McKenna is a Professor and Associate Dean (Programs) in the Department of Chemistry at the University of Manitoba, Faculty of Science. His research focuses on RNA-protein interactions in biological systems, combining biochemistry, structural biology, and molecular biology. He leads the McKenna Lab, investigating non-coding RNA roles in cancer and immune responses to viral infections. Key projects include studying BC200 long non-coding RNA in tumors and the regulation of 2'-5'-oligoadenylate synthetases in viral defense. His work is supported by grants from NSERC and CIHR. McKenna has supervised over 50 students and postdocs, many now in academic and industry roles. He co-launched White Otter Biotech, advancing environmental DNA/RNA monitoring. His lab recently renovated, now housing collaborations with the Ripstein group. Education: PhD (Biochemistry, University of Alberta), Postdoc (Stanford University), BSc (Queen's University). Awards include NSERC Discovery Grants, CIHR funding, and early-career accolades. Research spans RNA dynamics, cancer biology, and viral immunology. Research Highlights: Non-coding RNA BC200’s role in tumor proliferation 2'-5'-OAS enzymes in antiviral immunity SRP9/SRP14 regulation of Alu RNA Recent Publications: Over 70 articles, including work on Alu RNA mechanisms (RNA Biology, 2024) and BC200 processing (RNA Journal, 2024). Awards: NSERC (2024), CIHR (2020), Jamieson Scholarship (2021). Lab & Collaborations: McKenna-Ripstein lab merger (2024), White Otter Biotech (DNA/RNA biodiversity tech).

• Structural Biology
• Molecular Biophysics
• Cryo-Electron Microscopy
• +۹ مورد دیگر

David Agard is a Professor in the Department of Biochemistry and Biophysics at the University of California San Francisco (UCSF), where he leads a research group focused on uncovering the structural basis of biological function at the molecular and cellular levels. His lab specializes in advanced cryo-electron microscopy (cryo-EM) and fluorescence light microscopy, developing novel imaging technologies to study dynamic cellular processes. His research interests span structural biology , molecular chaperone function (particularly Hsp90 and its role in disease), microtubule nucleation , centrosome and cilium structure , and the structure of phage-encoded tubulins . He is deeply involved in methodological innovations in cryo-EM data processing , including deconvolution, heterogeneous reconstruction, and tomography, enabling atomic-level insights into complex biological systems. Recent publications highlight his lab’s work on the structural mechanisms of Hsp90-client regulation, microtubule organization, phage nucleus formation, and high-resolution imaging techniques using functionalized graphene-oxide grids. His work increasingly integrates AI-driven structural modeling and in situ approaches to understand macromolecular complexes in their native cellular context. Dr. Agard has made seminal contributions to understanding the ATPase cycle of Hsp90, the architecture of the gamma-tubulin complex, and the structural dynamics of viral and cellular tubulins. His research bridges biochemistry, biophysics, and cell biology, with implications for cancer, neurodegeneration, and antimicrobial strategies.

• Genomics
• Non-coding RNA research
• Phenotype-genotype relationships
• +۷ مورد دیگر

Professor Marcel Dinger is a prominent academic and researcher currently serving as Professor and Head of School for Biotechnology and Biomolecular Sciences at UNSW Sydney. With over 20 years of experience in genomics, he has established himself as a leading figure in both academic and entrepreneurial spheres within the field. He has published 153 papers with over 24,000 citations and maintains an h-index of 61 on Google Scholar. His leadership extends beyond academia as he serves as President of the Australasian Genomics Technologies Association (AGTA) and holds director positions at Pryzm Health and the National Centre for Indigenous Genomics (NCIG). Professor Dinger's research laboratory focuses on establishing new links between phenotype and genotype, particularly examining rare and complex diseases in relation to underexplored regions of the genome including pseudogenes, repetitive elements, non-canonical DNA structures, and noncoding RNAs. His work harnesses population-scale genomic datasets and sophisticated data science methods to bring an objective perspective to understanding how the genome stores information and how it is transacted in biology. His research interests span genomics, non-coding RNA biology, clinical applications of genomic medicine, and the development of computational approaches for analyzing complex genomic data. Analysis of Professor Dinger's recent publications reveals a strong emphasis on non-coding RNA research, particularly long noncoding RNAs and their roles in disease mechanisms. His work spans cancer genomics, neurological disorders, and fundamental genomic mechanisms including DNA secondary structures like i-motifs and G-quadruplexes. His research combines experimental approaches with advanced bioinformatics to address fundamental questions in genomic medicine and has significant translational implications for disease diagnosis and treatment. Highly Cited Researcher in Cross-Field category (2019, 2020, 2021) Fellow of the Faculty of Science (Research), Royal Society of Pathologists of Australasia (2016) NHMRC Career Development Award (2010) Queensland Government Smart Futures Fellowship (2009) Foundation of Research, Science and Technology New Zealand Postdoctoral Fellowship (2005) Professor Dinger has been instrumental in establishing and leading several significant research initiatives including Genome.One, one of the first companies globally to provide clinical whole genome sequencing services, and the Kinghorn Centre for Clinical Genomics at the Garvan Institute of Medical Research. His entrepreneurial experience includes founding four biotechnology and IT startups. He serves on multiple governance boards including the National Centre for Indigenous Genomics, focusing on using genomics to improve health outcomes for Australia's First Peoples. His laboratory at UNSW continues to advance our understanding of genomic regulation and its implications for human health and disease.